Skip to main content

Table 4 Liverpool active plaque score and its changes

From: Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology

 

DM (17 pts.)

Non-DM (44 pts.)

p

Baseline LAPS

0.0 ± 1.87

− 0.15 ± 2.06

0.36

Follow-up LAPS

0.13 ± 1.89

− 0.38 ± 1.8

0.002

Change of LAPS

0.13 ± 1.79

− 0.23 ± 1.66

0.018

p value (BL vs. FU)

0.5

0.06

 
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840